Climb Bio, Inc. CLYM on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001768446
0001768446
EIN:
83-2273741
83-2273741
LEI:
(CF Office: 03 Life Sciences)
Business address:
20 WILLIAM STREET, SUITE 145, WELLESLEY HILLS, MA, 02481
Phone: 1-866-857-2596
20 WILLIAM STREET, SUITE 145, WELLESLEY HILLS, MA, 02481
Phone: 1-866-857-2596
Mailing address:
20 WILLIAM STREET, SUITE 145, WELLESLEY HILLS, MA, 02481
20 WILLIAM STREET, SUITE 145, WELLESLEY HILLS, MA, 02481
Category:
Emerging growth company
Emerging growth company
Former names:
- Eliem Therapeutics, Inc. - filings through 2024-09-20
Filings:
219 EDGAR filings since February 19, 2019
219 EDGAR filings since February 19, 2019
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- April 1, 2025 - S-8: Securities to be offered to employees in employee benefit plans Open documentClick to Open document FilingOpen filingClick to Open filing
- April 1, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- March 25, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 1.01 - Entry into a Material Definitive Agreement
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- March 25, 2025 - 424B5: Prospectus [Rule 424(b)(5)] Open documentClick to Open document FilingOpen filingClick to Open filing
- March 25, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- April 1, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- March 25, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 1.01 - Entry into a Material Definitive Agreement
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- January 10, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 1.01 - Entry into a Material Definitive Agreement
- 2.02 - Results of Operations and Financial Condition
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- March 25, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 12, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 14, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 15, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- April 29, 2024 - 10-K/A: Annual report for year ending December 31, 2023 - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
No Proxy filings for this company in last 365 days
[+] Ownership disclosures
- Insider transactions
- April 1, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- April 1, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- April 1, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- February 13, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 14, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- August 16, 2024 - SC 13D/A: General statement of acquisition of beneficial ownership - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 48 of 219 entries
Data source:
CIK0001768446.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
